Postoperative Pain Management Market Size & Analysis for North America, Europe, APAC, South America, Middle East and Africa - US, UK, France, Germany, China – 2025-2029

Postoperative Pain Management Market Size 2025-2029

The postoperative pain management market size is forecast to increase by USD 10-13 billion at a CAGR of 5%-7% between 2025 and 2029. Exact values for this market can be accessed upon purchasing the report.

One major trend in the market is the increasing adoption of multimodal analgesia, which involves the use of multiple analgesics to target different pain mechanisms. Additionally, there is a rising focus on personalized pain management, with treatments tailored to individual patient needs. Furthermore, the growing demand for minimally invasive surgeries is influencing the market, as these procedures typically result in lower postoperative pain. However, challenges such as the high cost of advanced pain management technologies and the need for improved drug delivery systems persist. To stay competitive, companies in the market must focus on innovation, cost management, and addressing the diverse needs of postoperative patients. Overall, the market is expected to grow steadily in the coming years, driven by these trends and challenges.

To access the full market forecast and comprehensive analysis, Buy Now

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in USD billions for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Drug Class

• Opioids
• Non-steroidal anti-inflammatory drugs (NSAIDS)
• Cyclooxygenase-2-selective (COX-2) inhibitors
• Others

Route of Administration

• Injectable
• Oral
• Topical
• Others

Geography

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
• APAC
  • China
  • Japan
  • India
• South America
  • Brazil
• Middle East & Africa

Drug Class Insights

Opioids and non-opioid analgesics see widespread use in postoperative settings. However, the opioid crisis and increasing concerns about opioid dependency are driving demand for alternative pain management therapies. Regional anesthesia techniques are gaining popularity, as they provide effective pain relief with fewer side effects compared to systemic analgesics.

Regional Analysis

North America is expected to remain the largest market for postoperative pain management due to the high demand for advanced pain management systems, the increasing prevalence of surgeries, and a growing aging population. The region benefits from well-established healthcare infrastructure, high healthcare expenditure, and a favorable regulatory environment. European markets are also seeing steady growth, particularly in countries like Germany, the UK, and France, as they increasingly adopt multimodal and personalized pain management approaches.

Market Dynamics

Our postoperative pain management market researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Postoperative Pain Management Market?

The increasing shift toward multimodal analgesia is a primary factor driving the growth of the postoperative pain management market. By combining different types of analgesics, clinicians can reduce opioid usage, minimize side effects, and improve patient outcomes. Technological advancements, such as improved drug delivery systems and regional anesthesia techniques, are also supporting market growth. Furthermore, the increasing preference for minimally invasive surgeries, which result in less pain and quicker recovery times, is enhancing the demand for efficient pain management solutions. The rising number of surgeries globally, particularly in elderly populations, further contributes to the market's expansion.

What are the market trends shaping the Postoperative Pain Management Market?

Personalized pain management, which tailors pain relief strategies to the individual patient's needs and conditions, is becoming a key trend. This approach allows healthcare providers to optimize pain management regimens and reduce the risks associated with overuse of certain medications. The shift from traditional opioid-based pain relief to a broader range of therapies, including non-opioid analgesics and regional anesthesia, is also gaining traction. This trend is driven by increasing patient awareness, a growing understanding of pain mechanisms, and a focus on reducing opioid dependency.

What challenges does the Postoperative Pain Management Market face during the growth?

While the adoption of advanced postoperative pain management systems is on the rise, the high costs associated with cutting-edge technologies, such as regional anesthesia equipment and advanced drug delivery systems, can be a significant barrier, particularly in developing regions. Additionally, the global opioid crisis is leading to stricter regulations on opioid prescriptions, which may limit the availability of these medications in postoperative settings. These challenges could hinder market growth, but the ongoing shift toward alternative therapies is expected to alleviate some of the pressure.

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic partnerships, mergers and acquisitions, product launches, and technological advancements to strengthen their position in the postoperative pain management market.

This market research report includes detailed analyses of the competitive landscape of the market and information on close to 20 key companies, including:

• Abbott Laboratories
• Pfizer Inc.
• Eli Lilly and Co.
• Johnson & Johnson
• Merck & Co.
• Boston Scientific Corp.
• Medtronic plc
• Stryker Corporation
• B. Braun Melsungen AG
• Smith & Nephew plc

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment and the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Scope

Base Year	2024
Forecast Period	2025-2029
Market Size	USD 10-13 Billion
Market Growth	5%-7%
Drug Class	Opioids NSAIDS COX-2 inhibitors Others
Route of Administration	Injectable Oral Topical Others
Regional Landscape	North America Europe APAC South America Middle East and Africa
Key Companies Profiled	Abbott Laboratories Pfizer Inc. Eli Lilly and Co. Johnson & Johnson Merck & Co. Boston Scientific Corp. Medtronic plc Stryker Corporation B. Braun Melsungen AG Smith & Nephew plc Others

For further information, Get Free Sample

How the Benefits of a Technavio Market Research Report Can Empower Your Business

Technavio’s reports provide a range of market insights, including:

• A detailed analysis of the market, featuring market size, growth rate, segmentation, and regional performance
• In-depth analysis of the drivers, challenges, and other dynamics that will impact the growth of the market
• Predictions about upcoming trends and changes in consumer behavior
• Detailed information on key market players, including market positioning, product offerings, and more

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 2.2 Criticality of inputs and factors of differentiation
  • Overview on criticality of inputs and factors of differentiation

• 2.3 Factors of disruption
  • Overview on factors of disruption

• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 3.2 Market characteristics
  • Market characteristics analysis

• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition

• 4.2 Market segment analysis
  • Market segments

• 4.3 Market size 2024

• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Market 2019 - 2023
  • Historic Market Size - Data Table on Global Market 2019 - 2023 ($ billion)

• 5.2 Segment Analysis 2019 - 2023
  • Historic Market Size – Segment Analysis 2019 - 2023 ($ billion)

• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029

• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029

• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029

• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029

• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029

• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029

• 7.7 Market condition
  • Chart on market condition - Five forces 2024 and 2029

8 Market Segmentation

• 8.1 Market segments
  • Chart on Segmentation - Market share 2024-2029 (%)
  • Data Table on Segmentation - Market share 2024-2029 (%)

• 8.2 Segment Comparison
  • Chart on Comparison
  • Data Table on Comparison

• 8.3 Segment Market Opportunity
  • Market opportunity ($ billion)
  • Data Table on Market Opportunity ($ billion)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on market share by geography 2024-2029 (%)
  • Data Table on market share by geography 2024-2029 (%)

• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 10.3 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Tables on Market opportunity by geography ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview

• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 12.3 Landscape disruption
  • Overview on factors of disruption

• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered

• 13.2 Company ranking index
  • Company ranking index

• 13.3 Market positioning of companies
  • Matrix on companies position and classification

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 14.4 Research methodology
  • Research methodology

• 14.5 Data procurement
  • Information sources

• 14.6 Data validation
  • Data validation

• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 14.8 Data synthesis
  • Data synthesis

• 14.9 360 degree market analysis
  • 360 degree market analysis

• 14.10 List of abbreviations
  • List of abbreviations